Histogen Wins Motion for Summary Judgment in Patent Case, Defeating SkinMedica’s Claims

Histogen, Inc., a regenerative medicine company developing solutions based on the products of cells grown under simulated embryonic conditions, today announced that the United States District Court for the Southern District of California has granted the Company’s motion for summary judgment of non-infringement of patents in the lawsuit that SkinMedica, Inc. filed against Histogen in 2009.